Clinical Advances and State-of-the-Art Management in Genitourinary Cancers

Dear Colleagues,

Genitourinary (GU) malignancies represent a variety of tumors within the urinary and male reproductive systems, requiring individualized treatment plans to meet the distinct needs of each patient. Although most GU malignancies are well managed in the early stages, the advanced stages of many such cancers have a poor prognosis. Limited treatment options and poor prognosis represent an unmet need in advanced GU malignancies.

The development of novel therapies for advanced GU cancers relies on comprehension of underlying biological mechanisms, and several research efforts have focused on genomic profiling, diagnostic biomarkers, tumor immune microenvironment (TIME), and molecular pathways of oncogenesis.

The focus of this Special Issue is to consider research efforts pertaining to: (a) tumor biology, genomic characterization, and microenvironment; and (b) exploration of novel therapies in genitourinary malignancies.

Dr. Jad Chahoud
Guest Editor

Dr. Adnan Fazili
Guest Editor Assistant

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.